Phentermine Hydrochloride NDC 10702-029

NDC codes

FDA NDC Directory

Product NDC (as listed)10702-029Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10702-0029Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
10702-029-01	10702002901	100 CAPSULE in 1 BOTTLE (10702-029-01)Marketed from Aug 15, 2012
10702-029-03	10702002903	30 CAPSULE in 1 BOTTLE (10702-029-03)Marketed from Aug 15, 2012
10702-029-10	10702002910	1000 CAPSULE in 1 BOTTLE (10702-029-10)Marketed from Aug 15, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phentermine Hydrochloride
Generic name (nonproprietary): phentermine hydrochloride
Active ingredients: Phentermine hydrochloride — 37.5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: KVK-TECH, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040887
Marketing start: Aug 15, 2012
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Appetite Suppression (Physiologic effect)Increased Sympathetic Activity (Physiologic effect)
Identifiers: Product ID 10702-029_1159ef2a-b2ca-518e-e063-6394a90a7543SPL ID 1159ef2a-b2ca-518e-e063-6394a90a7543SPL set ID 3b44d104-a7d0-4366-9d42-63f784f3cb22RxCUI 803348, 803353UNII 0K2I505OTV
Pharmacologic class: Sympathomimetic Amine Anorectic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410702002901 followed by a unit qualifier and the quantity

Package 10702-0029-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 14, 2024.

Indications (excerpt from the label)

Phentermine hydrochloride, USP 37.5 mg is indicated as short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 30 kg/m 2 , or greater than or equal to 27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040887

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040887
Product	Strength	Form · route	Labeler	Product NDC
Phenterminephentermine hydrochloride	Phentermine hydrochloride 37.5 mg/1	CapsuleOral	Calvin Scott & Co., Inc.	17224-890
Phentermine Hydrochloride	Phentermine hydrochloride 37.5 mg/1	CapsuleOral	A-S Medication Solutions	50090-0653
Phentermine Hydrochloride	Phentermine hydrochloride 37.5 mg/1	CapsuleOral	PD-Rx Pharmaceuticals, Inc.	43063-182